MDT

86.12

+0.38%↑

A

121.33

+2.77%↑

VEEV

167.59

+1.04%↑

HQY

85.7

+1.56%↑

NEOG

9.53

+3.03%↑

MDT

86.12

+0.38%↑

A

121.33

+2.77%↑

VEEV

167.59

+1.04%↑

HQY

85.7

+1.56%↑

NEOG

9.53

+3.03%↑

MDT

86.12

+0.38%↑

A

121.33

+2.77%↑

VEEV

167.59

+1.04%↑

HQY

85.7

+1.56%↑

NEOG

9.53

+3.03%↑

MDT

86.12

+0.38%↑

A

121.33

+2.77%↑

VEEV

167.59

+1.04%↑

HQY

85.7

+1.56%↑

NEOG

9.53

+3.03%↑

MDT

86.12

+0.38%↑

A

121.33

+2.77%↑

VEEV

167.59

+1.04%↑

HQY

85.7

+1.56%↑

NEOG

9.53

+3.03%↑

Search

Savara Inc

Abrir

SetorSaúde

5.84 2.1

Visão Geral

Variação de preço das ações

24h

Atual

Mín

5.63

Máximo

5.88

Indicadores-chave

By Trading Economics

Rendimento

-2.7M

-32M

Funcionários

70

EBITDA

-3.9M

-33M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+95.04% upside

Dividendos

By Dow Jones

Próximos Ganhos

11 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

107M

1.2B

Abertura anterior

3.74

Fecho anterior

5.84

Sentimento de Notícias

By Acuity

48%

52%

156 / 348 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Neutral Evidence

Savara Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

16 de abr. de 2026, 23:26 UTC

Ações em Alta

Stocks to Watch: Netflix, Alcoa, Knight-Swift, NiSource

16 de abr. de 2026, 20:41 UTC

Grandes Movimentos do Mercado

Netflix Shares Slide After 2Q Outlook Misses Wall Street's Expectations

16 de abr. de 2026, 23:49 UTC

Conversa de Mercado

Amplitude's Pivot to Oil-Linked Supply Deal Catches Bull's Eye -- Market Talk

16 de abr. de 2026, 23:45 UTC

Conversa de Mercado

Nikkei May Decline After Hitting Record High -- Market Talk

16 de abr. de 2026, 23:33 UTC

Conversa de Mercado
Notícias Principais

Gold Edges Higher on Hopes for U.S.-Iran Deal -- Market Talk

16 de abr. de 2026, 22:51 UTC

Conversa de Mercado

Netflix Sees Signs That Podcasts May Boost Engagement -- Market Talk

16 de abr. de 2026, 22:08 UTC

Ganhos

Netflix Chair Reed Hastings to Leave Board in June -- 3rd Update

16 de abr. de 2026, 22:06 UTC

Ganhos

Lundin Mining: Earnings From Discontinued Ops in 1Q Expected to Be Positively Impacted by Unaudited Gain on Disposal of Eagle Mine, Totaling Approximately $4M >LUN.T

16 de abr. de 2026, 22:06 UTC

Ganhos

Lundin Mining: Pre-Announces Items Impacting 1Q Results

16 de abr. de 2026, 22:06 UTC

Ganhos

Lundin Mining: Items of Significant Impact in 1Q Expected to Include Unaudited Realized Losses on Derivative Contracts of Approximately $13M, Primarily Related to Gold Collar Contracts >LUN.T

16 de abr. de 2026, 22:06 UTC

Ganhos

Lundin Mining: Rev in 1Q Expected to Be Positively Impacted by Unaudited Provisional Pricing Adjustments on Prior-Period Concentrate Sales of Approximately $22M on Pre-Tax Basis >LUN.T

16 de abr. de 2026, 22:06 UTC

Ganhos

Lundin Mining: Adjustments Primarily Include Upward Adjustments in Relation to Prior-Period Metal Sales >LUN.T

16 de abr. de 2026, 20:50 UTC

Conversa de Mercado
Ganhos

Tech, Media & Telecom Roundup: Market Talk

16 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

16 de abr. de 2026, 20:50 UTC

Conversa de Mercado
Notícias Principais

Basic Materials Roundup: Market Talk

16 de abr. de 2026, 20:50 UTC

Conversa de Mercado
Ganhos

Health Care Roundup: Market Talk

16 de abr. de 2026, 20:49 UTC

Ganhos

SpaceX Is Ready to Go Public. The Stock Market Is Its Rocket. -- Barrons.com

16 de abr. de 2026, 20:43 UTC

Ganhos

Update: Netflix Stock Falls on Weak Guidance. Founder Reed Hastings Is Leaving the Board. -- Barrons.com

16 de abr. de 2026, 20:40 UTC

Conversa de Mercado
Ganhos

Global Equities Roundup: Market Talk

16 de abr. de 2026, 20:40 UTC

Conversa de Mercado
Ganhos

Netflix Says Engagement Quality Hits New High -- Market Talk

16 de abr. de 2026, 20:30 UTC

Ações em Alta

Stocks to Watch: TSMC, Abbott Laboratories, Nvidia, Netflix -- WSJ

16 de abr. de 2026, 20:25 UTC

Ganhos

Netflix Stock Falls on Weak Guidance. Founder Reed Hastings Is Leaving the Board. -- Barrons.com

16 de abr. de 2026, 20:23 UTC

Ganhos

These Stocks Are Today's Movers: AMD, Intel, TSMC, Abbott, Hims, Corning, Schwab, Polaris, and More -- Barrons.com

16 de abr. de 2026, 20:19 UTC

Ganhos

Netflix Guidance Disappoints. The Stock Is Down. -- Barrons.com

16 de abr. de 2026, 20:17 UTC

Ganhos

Alcoa: Alumina Costs in the Aluminum Segment Are Expected to Be Favorable by Approximately $20M Sequentially >AA

16 de abr. de 2026, 20:17 UTC

Ganhos

Alcoa: Based on Higher LME and Midwest Premium Pricing and Expected Higher Shipments, Section 232 Tariff Costs on U.S. Imports of Aluminum From Canada Expected to Increase $35M Sequentially >AA

16 de abr. de 2026, 20:16 UTC

Ganhos

Alcoa: Expects 2026 Total Aluminum Segment Production and Shipments Ranging Between 2.4M and 2.6M Metric Tons, and Between 2.6M and 2.8M Metric Tons, Respectively >AA

16 de abr. de 2026, 20:16 UTC

Ganhos

Alcoa: Expects 2026 Total Aluminum Segment Production and Shipments to Remain Unchanged From Its Prior Projection >AA

16 de abr. de 2026, 20:16 UTC

Ganhos

Alcoa: Expects 2026 Total Alumina Segment Production and Shipments Ranging Between 9.7M to 9.9M Metric Tons, and Between 11.8M and 12.0M Metric Tons, Respectively >AA

16 de abr. de 2026, 20:16 UTC

Ganhos

Alcoa: Expects 2026 Total Alumina Segment Production and Shipments to Remain Unchanged From Prior Projection >AA

Comparação entre Pares

Variação de preço

Savara Inc Previsão

Preço-alvo

By TipRanks

95.04% parte superior

Previsão para 12 meses

Média 11 USD  95.04%

Máximo 16 USD

Mínimo 9 USD

Com base em 5 analistas de Wall Street que oferecem metas de preço de 12 meses para Savara Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

5 ratings

5

Comprar

0

Manter

0

Vender

Pontuação Técnica

By Trading Central

2.76 / 2.84Suporte e Resistência

Curto Prazo

Neutral Evidence

Médio Prazo

Very Strong Bullish Evidence

Longo Prazo

Weak Bullish Evidence

Sentimento

By Acuity

156 / 348 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Savara Inc

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Langhorne, Pennsylvania.
help-icon Live chat